In today's Health Alert, the FDA has approved the first stand-alone nasal spray to treat drug-resistant depression.
Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.
A one-time nasal spray has been approved by the Food and Drug Administration as a standalone treatment for depression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback